Vertex Pharmaceuticals
VRTX
VRTX
483 hedge funds and large institutions have $17.4B invested in Vertex Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 172 increasing their positions, 191 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
10% less repeat investments, than reductions
Existing positions increased: 172 | Existing positions reduced: 191
1% less funds holding
Funds holding: 488 → 483 (-5)
17% less capital invested
Capital invested by funds: $20.9B → $17.4B (-$3.46B)
Holders
483
Holding in Top 10
5
Calls
$117M
Puts
$123M
Top Buyers
| 1 | +$146M | |
| 2 | +$99.5M | |
| 3 | +$65.3M | |
| 4 |
Two Sigma Advisers
New York
|
+$61.5M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$55.3M |
Top Sellers
| 1 | -$286M | |
| 2 | -$209M | |
| 3 | -$120M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$113M |
| 5 |
O
OppenheimerFunds
New York
|
-$75.4M |